Health care resource utilization (HCRU) and total costs of care (TCOC) among patients (pts) with diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor (CAR) T-cell therapies in the United States: An analysis of four claims databases.

被引：0
|
作者：
Keating, Scott J. [1 ]
Gu, Tao
Jun, Monika Parisi
Pelletier, Corey
McBride, Ali
机构：
[1] Bristol Myers Squibb Co, Summit, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 29期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
76
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United States
    Keating, Scott J.
    Gu, Tao
    Jun, Monika P.
    McBride, Ali
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 404.e1 - 404.e6
  • [2] HEALTH CARE RESOURCE UTILIZATION AND COSTS OF CAR T-CELL THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS IN THE US
    Davies, K.
    Kamalakar, R.
    Huang, Y.
    Wang, A.
    Sail, K.
    Doerr, T.
    Sharmokh, S.
    Mutebi, A.
    Salles, G.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S424 - S425
  • [3] Health Care Resource Utilization and Costs of CAR T Therapy in Patients with Large B-Cell Lymphoma: A Retrospective US Claims Database Analysis
    Davies, Kalatu R.
    Kamalakar, Rajesh
    Yu, Junhua
    Huang, Yinan
    Wang, Anthony
    Sail, Kavita
    Doerr, Thomas
    Sharmokh, Simon
    Mutebi, Alex
    Salles, Gilles
    [J]. BLOOD, 2022, 140 : 5058 - 5059
  • [4] HEALTH CARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH STEM CELL TRANSPLANTATION IN PATIENTS WITH LARGE B-CELL LYMPHOMA IN THE UNITED STATES
    Lunning, M.
    Do, Q.
    Liu, F. F.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S83 - S83
  • [5] Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United States
    Cui, Chendi
    Feng, Chaoling
    Rosenthal, Ning
    Wade, Sally W.
    Curry, Laura
    Fu, Christine
    Shah, Gunjan L.
    [J]. LEUKEMIA & LYMPHOMA, 2024, 65 (07) : 922 - 931
  • [6] Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United States
    Cui, Chendi
    Feng, Chaoling
    Rosenthal, Ning
    Wade, Sally W.
    Curry, Laura
    Fu, Christine
    Shah, Gunjan L.
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [7] Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma (DLBCL) - a Retrospective Health Claims Data Analysis
    Borchmann, Peter
    Papadimitrious, Michael S.
    Mahlich, Joerg
    Riou, Sybille
    Werner, Barbara
    [J]. BLOOD, 2022, 140 : 7932 - 7932
  • [8] IMPACT OF ADVERSE EVENTS (AES) ON HEALTHCARE RESOURCE UTILIZATION (HRU) AND TOTAL COSTS OF CARE (TCOC) AMONG PATIENTS WITH LARGE B-CELL LYMPHOMA (LBCL)
    McBride, A.
    Tian, M.
    Jun, M. P.
    Pelletier, C.
    Powers, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S49 - S49
  • [9] Hospital Costs and Healthcare Resource Utilization (HRU) for Chimeric Antigen (CAR) T-Cell Therapy and Stem Cell Transplant (SCT) in Patients with Large B-Cell Lymphoma (LBCL) in the United States (US)
    Cui, Chendi
    Feng, Chaoling
    Rosenthal, Ning
    Wade, Sally W.
    Curry, Laura
    Fu, Christine
    Shah, Gunjan L.
    [J]. BLOOD, 2022, 140 : 2161 - 2162
  • [10] Real-world treatment patterns among patients with diffuse large B-cell lymphoma (DLBCL) treated with CD19-directed chimeric antigen receptor T-cell therapy (CAR T).
    Jalbert, Jessica J.
    Arnason, Jon E.
    Ge, Wenzhen
    Chen, Chieh-, I
    Ambati, Srikanth R.
    Wu, Ning
    Chaudhry, Aafia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345